<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE resolution PUBLIC "-//US Congress//DTDs/res.dtd//EN" "res.dtd">
<resolution public-private="public" resolution-stage="Agreed-to-Senate" resolution-type="senate-resolution" star-print="no-star-print">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 SRES 242 ATS: Celebrating the 25th anniversary of the Office of Research on Women’s Health at the National Institutes of Health.</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2015-08-05</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">III</distribution-code>
		<congress display="yes">114th CONGRESS</congress>
		<session display="yes">1st Session</session>
		<legis-num>S. RES. 242</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action display="yes">
			<action-date date="20150805">August 5, 2015</action-date>
			<action-desc><sponsor name-id="S182">Ms. Mikulski</sponsor> (for herself, <cosponsor name-id="S252">Ms. Collins</cosponsor>, <cosponsor name-id="S361">Ms. Hirono</cosponsor>, <cosponsor name-id="S311">Ms. Klobuchar</cosponsor>, <cosponsor name-id="S229">Mrs. Murray</cosponsor>, <cosponsor name-id="S360">Ms. Heitkamp</cosponsor>, <cosponsor name-id="S221">Mrs. Feinstein</cosponsor>, <cosponsor name-id="S223">Mrs. Boxer</cosponsor>, <cosponsor name-id="S354">Ms. Baldwin</cosponsor>, <cosponsor name-id="S288">Ms. Murkowski</cosponsor>, <cosponsor name-id="S340">Ms. Ayotte</cosponsor>, <cosponsor name-id="S275">Ms. Cantwell</cosponsor>, <cosponsor name-id="S357">Mrs. Fischer</cosponsor>, <cosponsor name-id="S324">Mrs. Shaheen</cosponsor>, <cosponsor name-id="S366">Ms. Warren</cosponsor>, <cosponsor name-id="S331">Mrs. Gillibrand</cosponsor>, <cosponsor name-id="S312">Mrs. McCaskill</cosponsor>, <cosponsor name-id="S284">Ms. Stabenow</cosponsor>, <cosponsor name-id="S372">Mrs. Capito</cosponsor>, and <cosponsor name-id="S376">Mrs. Ernst</cosponsor>) submitted the following resolution; which was referred to the <committee-name committee-id="SSHR00">Committee on Health, Education, Labor, and Pensions</committee-name></action-desc>
		</action>
		<action><action-date>September 16, 2015</action-date><action-desc>Committee discharged; considered, amended, and agreed to with an amended preamble and an amendment
			 to the title</action-desc></action><legis-type>RESOLUTION</legis-type>
		<official-title display="yes">Celebrating the 25th anniversary of the Office of Research on Women’s Health at the
			 National Institutes of Health.</official-title>
	</form>
	<preamble commented="no">
 <whereas commented="no"><text display-inline="yes-display-inline">Whereas, on September 10, 1990, the Office of Research on Women’s Health (in this resolution referred to as <quote>ORWH</quote>) was established at the National Institutes of Health (in this resolution referred to as <quote>NIH</quote>) to—</text>
 <paragraph commented="no" display-inline="no-display-inline" id="idF4044E4FA24E4ED4B3E0836554C33D40"><enum>(1)</enum><text display-inline="yes-display-inline">ensure that women were included in NIH-funded clinical research;</text> </paragraph><paragraph commented="no" display-inline="no-display-inline" id="id284099A44A1549688CECA203CBBBEC07"><enum>(2)</enum><text display-inline="yes-display-inline">set research priorities to address gaps in scientific knowledge; and</text>
 </paragraph><paragraph commented="no" display-inline="no-display-inline" id="id55F1D6C31CC149F58279D94D2FD5281E"><enum>(3)</enum><text display-inline="yes-display-inline">promote biomedical research careers for women;</text> </paragraph></whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas ORWH was established in law by the National Institutes of Health Revitalization Act of 1993 (<external-xref legal-doc="public-law" parsable-cite="pl/103/43">Public Law 103–43</external-xref>; 107 Stat. 122) and implemented the law requiring researchers to include women in NIH-funded tests of new drugs and other clinical trials;</text>
 </whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas today, more than <fraction>1/2</fraction> of the participants in NIH-funded clinical trials are women, enabling the development of clinical approaches to prevention, diagnosis, or treatment appropriate for women;</text>
 </whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas, in 2015, ORWH, with enthusiastic support from NIH leadership, announced that, beginning in January 2016, NIH-funded scientists must account for the possible role of sex as a biological variable in vertebrate animal and human studies;</text>
 </whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas ORWH, along with NIH leadership, enhances awareness of the need to adhere to principles of rigor and transparency, including the need to publish sex-specific results to inform the treatment of women, men, boys, and girls;</text>
 </whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas over the past 25 years, ORWH has helped expand research on women’s health beyond its roots in reproductive health to include—</text>
 <paragraph commented="no" display-inline="no-display-inline" id="idE187F48C2C5A4D4597A44C51F704A3C3"><enum>(1)</enum><text display-inline="yes-display-inline">the study of the health of women across the lifespans of women; and</text> </paragraph><paragraph commented="no" display-inline="no-display-inline" id="idC49FB1477C9743E1A0BB57F9B8B34E94"><enum>(2)</enum><text display-inline="yes-display-inline">biomedical and behavioral research from cells to selves;</text>
 </paragraph></whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas by studying both sexes, ORWH is leading the scientific community to make discoveries headed toward treatments that are more personalized for both women and men;</text>
 </whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas today, ORWH communicates through programs and policies that sex and gender affect health, wellness, and how diseases progress;</text>
 </whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas turning discovery into health for all, the NIH motto, means studying both females and males across the biomedical research continuum;</text>
 </whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas the ORWH Specialized Centers of Research on Sex Differences program supports established scientists who do basic, clinical, and translational research with a sex and gender focus;</text>
 </whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas all NIH Institutes and Centers fund and encourage scientists at universities across the Nation to conduct research on the health of women and on sex and gender influences;</text>
 </whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas over the past 25 years, ORWH has established several career-enhancement initiatives for women in biomedicine, including the Building Interdisciplinary Research Careers in Women’s Health program that connects junior faculty with mentors who share interests in women’s health research;</text>
 </whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas ORWH co-directs the NIH Working Group on Women in Biomedical Careers, which develops and evaluates policies to promote the recruitment, retention, and sustained advancement of women scientists;</text>
 </whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas the Women’s Health Initiative (in this resolution referred to as <quote>WHI</quote>) marked the first long-term study of its kind and resulted in a wealth of information so that women and their physicians can make more informed decisions regarding postmenopausal hormone therapy;</text>
 </whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas WHI reduced the incidence of breast cancer by 10,000 to 15,000 cases per year, and the overall health care savings far exceeded the WHI investment;</text>
 </whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas ORWH supported the National Cancer Institute’s development of a vaccine that prevents the transmission of Human Papilloma Virus, resulting in a decrease in the number of cases of cervical cancer;</text>
 </whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas, in 1994, ORWH co-sponsored with the National Institute of Allergy and Infectious Diseases a landmark study, the results of which showed that giving the drug AZT to HIV-infected women with little or no prior antiretroviral therapy reduced the risk of mother-to-child transmission of HIV by <fraction>2/3</fraction>;</text>
 </whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas according to the Centers for Disease Control and Prevention, perinatal HIV infections in the United States have dropped by more than 90 percent;</text>
 </whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas ORWH co-funded a large clinical study of the genetic and environmental risk factors for ischemic stroke, which identified a strong relationship between the number of cigarettes smoked per day and the probability of ischemic stroke in young women, prompting the targeting of smoking as a preventable and modifiable risk factor for cerebrovascular disease in young women; and</text>
 </whereas><whereas commented="no"><text display-inline="yes-display-inline">Whereas over the past 25 years, ORWH has contributed support toward major advances in knowledge about the genetic risk for breast cancer, and discovery of the BRCA1 and BRCA2 genetic risk markers has enabled better-informed genetic counseling and treatment for members of families that carry mutant alleles: Now, therefore, be it</text></whereas></preamble><resolution-body display-resolving-clause="yes-display-resolving-clause" style="OLC">
 <section commented="no" display-inline="yes-display-inline" id="S1" section-type="undesignated-section"><enum></enum><text display-inline="yes-display-inline">That the Senate—</text> <paragraph commented="no" display-inline="no-display-inline" id="id386C03CF063A40A08F90F510CE86C0A9"><enum>(1)</enum><text display-inline="yes-display-inline">commends ORWH for its work over the past 25 years to improve and save the lives of women worldwide and expresses that ORWH must remain intact for this and future generations;</text>
 </paragraph><paragraph commented="no" display-inline="no-display-inline" id="id0b719c744ab64164b71ec7f6a110a228"><enum>(2)</enum><text display-inline="yes-display-inline">recognizes that there remain striking sex and gender differences among many diseases and conditions on which ORWH should continue to focus;</text>
 </paragraph><paragraph commented="no" display-inline="no-display-inline" id="id0DA0146B9CDE4043A5B3D60249B33E88"><enum>(3)</enum><text>encourages ORWH to continue to focus on ensuring that NIH supports biomedical research that considers sex as a biological variable across the research spectrum; and</text>
 </paragraph><paragraph commented="no" display-inline="no-display-inline" id="idB03A7A3EB98E476E99B01463E520C6D0"><enum>(4)</enum><text>encourages the Director of the NIH to continue to consult and involve ORWH on all matters related to the influence of sex and gender on health, especially those matters pertaining to the consideration of sex as a biological variable in research with vertebrate animals and humans.</text></paragraph></section></resolution-body>
</resolution>


